Shanghai Shibei Hi-Tech Co launched an innovation center on May 6 at Stanford University, marking a step in their collaboration with the Silicon Valley of the United States.
High-tech giant Illumina Inc plans to expand its operation in China after recording high double-digit growth in the past two years.
A biomedicine industry report meeting was recently held in Shanghai's Pudong New Area with the participation of more than 200 experts from the city's medical and pharmaceutical companies, research institutes, and government departments.
German pharmaceutical giant Boehringer Ingelheim announced Tuesday that its China Biopharmaceuticals Site has officially been put into operation.
In November 2015, the State Council was authorized to launch pilot Marketing Authorization Holder program in 10 provinces and municipalities, providing policy breakthrough and legal basis for biopharma Contract Manufacturing.
China Aerospace Science and Technology Corp and several other State-owned enterprises jointly set up a 150-billion-yuan ($21.8 billion) fund on Tuesday, to bolster China's new emerging industries, which will play a key role in the nation's upgrading efforts.
The Sinochem International Technological Innovation Center opened at Shanghai’s Zhangjiang High Tech Park on May 10, serving as an R&D platform of China's agrochemical industry.
As China continues to promote the development of the biopharmaceutical industry, Shanghai's Zhangjiang National Innovation Demonstration Zone is looking into innovative models through which to boost the industry's development.